Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9247
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-07-18T14:07:26Z-
dc.date.available2022-07-18T14:07:26Z-
dc.date.issued2011-03-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9247-
dc.subjectLeucemia Mielogênica Crônica BCR-ABL Positivapt_BR
dc.subjectLeukemia, Myelogenous, Chronic, BCR-ABL Positivept_BR
dc.subjectLeucemia Mielógena Crónica BCR-ABL Positivapt_BR
dc.subjectMétodospt_BR
dc.subjectMethodspt_BR
dc.titlePesquisadores do CEMO integram estudo que desvenda morte celular programada na Leucemia Mieloide Crônicapt_BR
dc.title.alternativeInforme INCA 286pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 286

Files in This Item:
File Description SizeFormat 
Informe INCA 286-3.pdf59.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.